Loading…
Valneva SE is projected to rise to $7.88 by 2027, a +24% move from its current price of $6.34. VALN is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $6.15 | $6.34 | $6.54 | +0.01% |
| May 30 | $6.07 | $6.34 | $6.62 | +0.01% |
| May 31 | $6.02 | $6.34 | $6.68 | +0.02% |
| Jun 1 | $5.97 | $6.34 | $6.74 | +0.02% |
| Jun 2 | $5.92 | $6.34 | $6.79 | +0.03% |
| Jun 3 | $5.89 | $6.34 | $6.83 | +0.04% |
| Jun 4 | $5.85 | $6.34 | $6.88 | +0.04% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $5.85 | $6.34 | $6.88 | +0.04% |
| Week 2 | $5.66 | $6.35 | $7.11 | +0.08% |
| Week 3 | $5.52 | $6.35 | $7.30 | +0.12% |
| Week 4 | $5.41 | $6.35 | $7.46 | +0.17% |
| Week 5 | $5.31 | $6.35 | $7.61 | +0.21% |
| Week 6 | $5.22 | $6.36 | $7.74 | +0.25% |
| Week 7 | $5.14 | $6.36 | $7.87 | +0.29% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Valneva SE is a healthcare company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs. It offers IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; DUKORAL, an oral vaccine for the prevention of diarrhea caused by Vibrio cholera or heat-labile toxin producing enterotoxigenic Escherichia coli bacterium; and IXCHIQ/ VLA1553, a single-dose, live-attenuated vaccine for the prevention of disease caused by chikungunya virus. The company also develops VLA15, a vaccine candidate against Borrelia, S4V2, a tetravalent bioconjugate vaccine candidate against shigellosis, VLA1601, a vaccine candidate targeting the Zika virus, VLA1554, a vaccine candidate targeting human metapneumovirus, VLA84, a vaccine candidate targeting the prevention of primary symptomatic clostridium difficile infection, and VLA2112, a vaccine candidate to treat patients with epstein-barr virus.
It sells its products in the United States, Canada, Germany, Austria, Nordics, the United Kingdom, France, rest of Europe, and internationally. Valneva SE was founded in 1998 and is based in Saint-Herblain, France.
Valneva SE (VALN) is a healthcare stock with a current price of $5.93 and a market cap of $562.3M. It is ranked 2953 in size. The near-term sentiment is NEUTRAL, and the stock sits within a price context defined by a 30-day range and a set of moving averages.
The multi-year forecast paints a bullish path after 2026, with progressively higher average prices and ROIs through 2050.
A major floor 24.6% below — a decisive break under it would weaken the trend.
The nearest floor, 18.5% below — buyers have tended to step in here.
Price is pressing into resistance (0.0% away) — a breakout level to watch.
A major ceiling 89.1% above — clearing it would confirm fresh momentum.
Key VALN support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of VALN market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $6.02 | Buy | $6.07 | Buy |
| MA 10 | $5.91 | Buy | $5.95 | Buy |
| MA 20 | $5.72 | Buy | $5.90 | Buy |
| MA 50 | $6.28 | Buy | $6.54 | Sell |
| MA 100 | $8.22 | Sell | $7.44 | Sell |
| MA 200 | $8.85 | Sell | $7.93 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 58.29 | Neutral |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | 149.43 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.13 | Buy |
| ROC (12) | 13.42 | Buy |
| Bollinger %B (20,2) | 0.97 | Neutral |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | -0.40 | Sell |
| Awesome (5,34) | 0.26 | Buy |
| Ultimate (7,14,28) | 80.94 | Sell |
| Momentum (10) | 0.34 | Buy |
| Aroon Osc (25) | 64.00 | Buy |
| Hull MA (9) | 6.14 | Buy |
| ADX (14) | 19.92 | Neutral |
| ATR (14) | 0.16 | Info |
The 30-day technical picture is NEUTRAL, with a RSI14 of 50. The SMA50 is $6.45 and the SMA200 is $8.88. Near-term support sits at $5.17 and resistance at $6.30. The 30-day price range runs from $4.85 to $7.25, indicating a contained trading band around the current level.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $5.17 | $6.34 | $8.93 | 0% | Neutral | |
| $6.18 | $7.88 | $10.69 | +24% | Bullish | |
| $7.19 | $9.45 | $13.33 | +49% | Bullish | |
| $8.45 | $11.40 | $16.58 | +80% | Bullish | |
| $7.98 | $11.02 | $16.45 | +74% | Bullish | |
| $7.94 | $11.19 | $17.09 | +77% | Bullish | |
| $8.71 | $12.52 | $19.52 | +98% | Bullish | |
| $8.71 | $12.76 | $20.26 | +101% | Bullish | |
| $10.51 | $15.67 | $25.31 | +147% | Bullish | |
| $12.00 | $18.19 | $29.85 | +187% | Bullish | |
| $13.79 | $22.59 | $39.61 | +256% | Bullish | |
| $26.37 | $49.47 | $95.47 | +680% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $5.17 | $6.34 | $7.47 | +0.00% |
| June 2026 | $5.36 | $6.31 | $7.61 | -0.52% |
| July 2026 | $5.36 | $6.37 | $7.81 | +1.07% |
| August 2026 | $5.64 | $6.76 | $8.38 | +6.01% |
| September 2026 | $5.73 | $6.91 | $8.64 | +2.22% |
| October 2026 | $5.58 | $6.76 | $8.53 | -2.14% |
| November 2026 | $5.60 | $6.82 | $8.67 | +0.95% |
| December 2026 | $5.70 | $6.98 | $8.93 | +2.24% |
Click any year to see its month-by-month VALN forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, VALN is projected to trade between $5.17 and $8.93, averaging $6.34 — a potential gain of 0% from today's $6.34. Price action looks broadly range-bound.
Valneva SE's 2027 outlook centres on $7.88, within a $6.18 to $10.69 range. That is up +24% on the projected 2026 average. That marks a +24% change versus current levels. Buyers look set to stay in control over this stretch.
By 2028, VALN could reach as high as $13.33, with a base case around $9.45 and support toward $7.19 — roughly +49% from $6.34. Momentum favours further upside here.
Expect VALN to range from $8.45 to $16.58 through 2029. The $11.40 average target implies a +80% move from current prices. That is up +21% on the projected 2028 average. Buyers look set to stay in control over this stretch.
The VALN price prediction for 2030 points to an average of $11.02 (low $7.98, high $16.45) — a potential gain of +74% on today's $6.34. Momentum favours further upside here.
In 2031, VALN is projected to trade between $7.94 and $17.09, averaging $11.19 — a potential gain of +77% from today's $6.34. That is up +2% on the projected 2030 average. Buyers look set to stay in control over this stretch.
Valneva SE's 2032 outlook centres on $12.52, within a $8.71 to $19.52 range. That is up +12% on the projected 2031 average. That marks a +98% change versus current levels. Momentum favours further upside here.
By 2033, VALN could reach as high as $20.26, with a base case around $12.76 and support toward $8.71 — roughly +101% from $6.34. Buyers look set to stay in control over this stretch.
Expect VALN to range from $10.51 to $25.31 through 2034. The $15.67 average target implies a +147% move from current prices. That is up +23% on the projected 2033 average. Momentum favours further upside here.
The VALN price prediction for 2035 points to an average of $18.19 (low $12.00, high $29.85) — a potential gain of +187% on today's $6.34. Buyers look set to stay in control over this stretch.
In 2040, VALN is projected to trade between $13.79 and $39.61, averaging $22.59 — a potential gain of +256% from today's $6.34. That is up +24% on the projected 2035 average. Momentum favours further upside here.
Valneva SE's 2050 outlook centres on $49.47, within a $26.37 to $95.47 range. That is up +119% on the projected 2040 average. That marks a +680% change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in VALN today (≈ 157.728707 VALN) could be worth
$7,802.53
+$6,802.53 (+680%) by 2050 · US Dollar
Based on the average projected VALN price of $49.47 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in VALNwould be worth at today's price.
$1,000 invested in VALN on May 27, 2025 (≈ 156.739809 VALN) would be worth
$993.73
-$6.27 (-0.6%) today · 0.99× · US Dollar
Based on a VALN entry price of $6.38 vs. today's $6.34.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $5.92 | $1,070.95 | +7.1% |
| 1 month ago | $5.49 | $1,154.83 | +15.5% |
| 3 months ago | $10.94 | $579.52 | -42.0% |
| 6 months ago | $9.35 | $677.71 | -32.2% |
| 1 year ago | $6.38 | $993.73 | -0.6% |
| All time (5.0y) ago | $29.08 | $218.02 | -78.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our VALN forecast.
Our base-case forecast reaches $13.00 around 2034.
Implied market cap at $13.00: $1.23B
The multi-year forecast turns bullish after 2026, with rising averages and ROIs across the years. In 2027 the average price is projected at $7.17 with an ROI of 20.9 and a bullish sentiment. The path continues higher through 2028 ($8.63 average, ROI 45.6) and 2029 ($10.31 average, ROI 73.9) before softening slightly in 2030 ($9.85 average, ROI 66) but remaining bullish.
By 2031 the average is $10.02 (ROI 69), by 2032 $11.13 (ROI 87.7), by 2033 $11.14 (ROI 87.8), and by 2034 $13.66 (ROI 130.4). The ascent continues to 2035 ($15.86 average, ROI 167.4) and strengthens further into 2040 ($19.46 average, ROI 228.2). The long-run horizon shows a very large potential, with 2050 average projected at $41.73 and ROI of 603.6, under a bullish outlook with upside potential and inherent uncertainty.
Tap a question to reveal the answer.
2030: min $7.13, avg $9.85, max $14.71; ROI 66; sentiment BULLISH.
From 2027 onward the forecast is bullish with rising averages and ROIs (e.g., 2027 avg $7.17; ROI 20.9; 2028 avg $8.63; ROI 45.6; 2029 avg $10.31; ROI 73.9; 2030 avg $9.85; ROI 66; 2031 avg $10.02; ROI 69).
Yes. The forecast maximum reaches $22.08 in 2034 and $26.04 in 2035, indicating a path that crosses $20 within the forecast horizon.
Current price is $5.93 and market cap is $562.3M. The stock is ranked 2953.
2040: avg $19.46, ROI 228.2. 2050: avg $41.73, ROI 603.6. Both years carry a bullish sentiment.
Valneva SE Community Discussion
0Share your Valneva SE price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.